摘要
目的:探讨单孔胸腔镜肺叶切除及系统性淋巴结清扫手术治疗肺癌的效果。方法:选取2019年1月-2022年2月九江市第一人民医院心胸外科肺癌患者80例,依据手术方法分为肺叶切除组(单孔胸腔镜肺叶切除及系统性淋巴结清扫手术)、肺段切除组(单孔胸腔镜肺段切除及系统性淋巴结清扫手术),各40例。统计分析两组疼痛程度、淋巴细胞百分比、嗜中性粒细胞百分比、生活质量、围术期指标、术后并发症发生情况、外观满意度。结果:术后1周,肺叶切除组患者的视觉模拟评分法(VAS)评分、淋巴细胞百分比、嗜中性粒细胞百分比均低于肺段切除组,生活质量测定量表简表(QOLBREF)评分高于肺段切除组(P<0.05)。肺叶切除组和肺段切除组患者的术中出血量、淋巴结清扫数、手术时间、引流管放置时间、总引流量、住院时间、住院费用比较,差异均无统计学意义(t=1.692、1.056、0.604、0.362、1.212、1.465、1.085,P>0.05)。两组患者的术后并发症发生率比较,差异无统计学意义(χ^(2)=0.139,P>0.05)。肺叶切除组患者的外观满意度95.00%(38/40)高于肺段切除组77.50%(31/40)(χ^(2)=5.165,P<0.05)。结论:单孔胸腔镜肺叶切除及系统性淋巴结清扫手术治疗肺癌的效果较好,能有效减轻患者疼痛,减轻患者炎症反应,提升患者生活质量及外观满意度,且不会增加患者术后并发症的发生,安全性有保证。
Objective:To investigate the effect of single-port thoracoscopic lobectomy and systematic lymph node dissection in the treatment of lung cancer.Method:From January 2019 to February 2022,80 patients with lung cancer in the Department of Cardiothoracic Surgery of Jiujiang NO.1 People’s Hospital were selected,according to surgical methods,the patients were divided into lobectomy group(single-port thoracoscopic lobectomy and systematic lymph node dissection)and segmentectomy group(single-port thoracoscopic lobectomy and systematic lymph node dissection),with 40 cases in each group.The levels of pain,lymphocyte percentage,neutrophil percentage,quality of life,perioperative indicators,postoperative complications and appearance satisfaction were statistically analyzed between the two groups.Result:1 week after operation,the visual analogue scale(VAS)score,percentage of lymphocytes,and percentage of neutrophils in the lobectomy group were lower than those in the segmentectomy group,and the QOL-BREF score was higher than the that of the segmentectomy group(P<0.05).There were no significant differences in intraoperative blood loss,lymph node dissection number,operation time,drainage tube placement time,total drainage flow,length of stay and hospitalization cost between the lobectomy group and segmental pulmonary resection group(t=1.692,1.056,0.604,0.362,1.212,1.465,1.085,P>0.05).There was no significant difference in the incidence of postoperative complications between the two groups(χ^(2)=0.139,P>0.05).The appearance satisfaction of lobectomy group was 95.00%(38/40)higher than 77.50%(31/40)of segmental resection group(χ^(2)=5.165,P<0.05).Conclusion:Single-port thoracoscopic lobotomy and systematic lymph node dissection have good efficacy in the treatment of lung cancer,which can effectively relieve patients’pain,reduce patients’inflammatory response,improve patients’quality of life and appearance satisfaction,without increasing the occurrence of postoperative complications,ensuring safety.
作者
许明发
彭勇波
郭颖
陈胜家
XU Mingfa;PENG Yongbo;GUO Ying;CHEN Shengjia(Jiujiang NO.1 People’s Hospital,Jiangxi Province,Jiujiang 332000,China;不详)
出处
《中国医学创新》
CAS
2022年第17期18-21,共4页
Medical Innovation of China
关键词
肺癌
单孔
胸腔镜肺叶切除
系统性淋巴结清扫手术
炎症因子
Lung cancer
Single port
Thoracoscopic lobectomy
Systematic lymph node dissection
Inflammatory cytokines
